Sapphiros Is Pleased To Announce OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests In Sapphiros
January 4, 2024 – “Our relationship with OraSure is a significant milestone for Sapphiros, and we are excited to partner with an organization that shares our focus on expanding access to diagnostic insights. We believe OraSure’s existing commercial infrastructure will allow us to quickly and efficiently scale following regulatory approvals to the populations that need […]
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement
BOSTON, Nov. 22, 2023 /PRNewswire/ – Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has entered into a distribution agreement with Cencora, Inc., formerly AmerisourceBergen Corporation. Under the agreement, Cencora will distribute the Sapphiros GoToKnow™ COVID-19 Antigen Rapid Tests to pharmacies across the United […]
Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device
BOSTON, Sept. 26, 2023 /PRNewswire/ – Satio is pleased to announce a $3.5 million Small Business Innovation Research (SBIR) contract awarded by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services. This SatioRxTM device is designed to be compact and inexpensive, with disposable microneedle components that […]
Satio Partners with BARDA DRIVe to Develop a Novel Patch-based Ebolavirus Diagnostic
Satio is pleased to announce a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to develop a novel, single-use, rapid ebolavirus diagnostic. This groundbreaking diagnostic will combine Satio’s patch-based blood collection device with Institut […]
Sapphiros Appoints Industry Veteran Andrew Garfield to Lead Technology Transfer to Manufacturing
BOSTON, July 17, 2023 /PRNewswire/ — Sapphiros, a platform dedicated to building the next generation of consumer diagnostics, is pleased to announce the appointment of Andrew Garfield as its new Vice President of Operations. Mr. Garfield will be responsible for transfer to manufacture, manufacturing operations and ensuring end-to-end supply chain resilience and continuity. Mark Gladwell, […]
GrapheneDx, General Graphene Corp and Sapphiros Enter Into Strategic Partnership to Industrialize Graphene-Based Biosensors to Revolutionize Point of Care and Consumer Diagnostics
BOSTON and KNOXVILLE, Tenn., Jun. 6, 2023 /PRNewswire/ — Today, GrapheneDxTM, General Graphene Corporation and SapphirosTM announce a strategic partnership to industrialize graphene-based biosensors for medical devices used to diagnose a variety of diseases at the point-of-care and in consumer settings. GrapheneDx is an in vitro diagnostics company focused on improving diagnostic capability at the […]
Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test
BOSTON, Apr. 17, 2023 /PRNewswire/ — Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has been selected by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to develop a high performance, over-the-counter (OTC), molecular multiplex respiratory diagnostic test that can […]
Sapphiros Taps Teresa Abraham for VP of Scientific and Technical Affairs
BOSTON, Jan. 25, 2023 /PRNewswire/ — Sapphiros, a platform dedicated to building the next generation of consumer diagnostics, backed by KKR, is pleased to announce the appointment of Teresa Abraham, PhD, as its new Vice President of Scientific and Technical Affairs. Dr. Abraham will be responsible for partnerships that accelerate technology development and clinical research […]
Biocrucible, a Sapphiros Company, Appoints Per Grufman as CEO
CAMBRIDGE, U.K., Jan. 20, 2023 /PRNewswire/ — Biocrucible, a Sapphiros platform company dedicated to building the next generation of consumer diagnostics, announced the appointment of Per Grufman, Ph.D., as its Chief Executive Officer. A biotech industry veteran of thirty years, Dr. Grufman will lead the development and commercialization of Biocrucible’s isothermal amplification technologies for next-generation […]
Sapphiros Appoints Mark Gladwell as CEO and President
BOSTON, Oct. 27, 2022 /PRNewswire/ — Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros’s Chief Operating Officer (“COO”) to President and Chief Executive Officer (“CEO”). Namal Nawana, founder of Sapphiros, will continue to remain closely involved as Executive Chairman. Namal Nawana, Sapphiros […]